Arteriovenous Malformation clinical trials at UC Health
1 research study open to new patients

• Bevacizumab Therapy for Brain Arteriovenous Malformation

  open to eligible people ages 18-64

  Bevacizumab Therapy for brain arteriovenous malformation that is not amenable to surgical intervention.

  at UCSF

Last updated: October 30, 2018